Epilepsy is a common neurological disease that affects approximately 50 million people worldwide [1]. It is defined as a disorder of the brain and characterised by an enduring predisposition to generate epileptic seizures [2,3]. Multiple antiepileptic drugs (AEDs) have been developed to try to control seizures in patients with epilepsy; however, 20–30% of patients are still refractory to currently available drug treatments, thus, the development of novel AEDs is required [4–6].

Read More...

Leave a comment.

Your email address will not be published. Required fields are marked*

Andoird App
Loading...